Robert S Hong, MD | |
30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 | |
(248) 865-4135 | |
(248) 865-6161 |
Full Name | Robert S Hong |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 21 Years |
Location | 30055 Northwestern Hwy, Farmington Hills, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447469820 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 4301095777 (Michigan) | Secondary |
207YX0901X | Otolaryngology - Otology & Neurotology | 4301095777 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
Munson Medical Center | Traverse city, MI | Hospital |
St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Michigan Ear Institute Pllc | 5597735514 | 30 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).
The Canadian Diabetes Association applauds the Government of Saskatchewan for increasing access to insulin detemir for residents of Saskatchewan living with diabetes. Insulin detemir, also known as Levemir, has been added to the Saskatchewan Drug Formulary, under Exception Drug Status (EDS) effective July 1, 2009. As well, the updated formulary now includes NovoRapid-NOO, Apidra-AVT and Humalog-LIL within its Revised Exception Drug Status Criteria.
Sexual intercourse is the major mode of HIV transmission. HIV may also be transmitted through sharing of needles or contaminated blood products (although this is rare).
Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
› Verified 8 days ago
Entity Name | Michigan Ear Institute Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568575215 PECOS PAC ID: 5597735514 Enrollment ID: O20040728000359 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).
The Canadian Diabetes Association applauds the Government of Saskatchewan for increasing access to insulin detemir for residents of Saskatchewan living with diabetes. Insulin detemir, also known as Levemir, has been added to the Saskatchewan Drug Formulary, under Exception Drug Status (EDS) effective July 1, 2009. As well, the updated formulary now includes NovoRapid-NOO, Apidra-AVT and Humalog-LIL within its Revised Exception Drug Status Criteria.
Sexual intercourse is the major mode of HIV transmission. HIV may also be transmitted through sharing of needles or contaminated blood products (although this is rare).
Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Robert S Hong, MD 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334-3230 Ph: (248) 865-4135 | Robert S Hong, MD 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Ph: (248) 865-4135 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).
The Canadian Diabetes Association applauds the Government of Saskatchewan for increasing access to insulin detemir for residents of Saskatchewan living with diabetes. Insulin detemir, also known as Levemir, has been added to the Saskatchewan Drug Formulary, under Exception Drug Status (EDS) effective July 1, 2009. As well, the updated formulary now includes NovoRapid-NOO, Apidra-AVT and Humalog-LIL within its Revised Exception Drug Status Criteria.
Sexual intercourse is the major mode of HIV transmission. HIV may also be transmitted through sharing of needles or contaminated blood products (although this is rare).
Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.
› Verified 8 days ago
Casey Ashby, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 28080 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8000 | |
Anuja Dharap, Otolaryngology Medicare: Medicare Enrolled Practice Location: 35630 Grand River Ave Apt 217, Farmington Hills, MI 48335 Phone: 716-495-9800 | |
Dr. Dennis I Bojrab, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 Fax: 248-865-6161 | |
Dr. Michael J Larouere, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 Fax: 248-865-6161 | |
Dr. Eric W Sargent, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 Fax: 248-865-6161 | |
Dr. Alice D Lee, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 30055 Northwestern Hwy, Suite 101, Farmington Hills, MI 48334 Phone: 248-865-4444 |